<DOC>
	<DOC>NCT00163150</DOC>
	<brief_summary>The main purpose of this study is to evaluate the efficacy of atorvastatin treatment during 3 months (80mg/day) on cerebral vasoreactivity (CVR) in lacunar patients.</brief_summary>
	<brief_title>Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Cerebral Small Vessel Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>clinically defined lacunar syndrome 3 months before inclusion small deep infarct on diffusion MRI (Diffusion Weighted Imaging) no atherothrombotic, cardioembolic, or other rarer cause. patients with past coronary event contraindication for assessment of vasomotor reactivity patients being on statin therapy at the time of brain infarction contraindication for statin therapy patient still under statin therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>